DYRK1A and Down syndrome: They attribute the effectiveness of EGCG to its ability to cross the blood–brain barrier and noncompetitive inhibition of tyrosine-(Y)-phosphorylation-regulated kinase 1A encoded by the DYRK1A gene, located on the long arm of chromosome 21 and postulated to be a key contributor to cognitive phenotypes of Down syndrome [7].